Physician profile
Natalie Marte
NPI 1972044188
$471.69
in general payments reported to CMS, 2019-2025
8 companies · $25.74 in 2025
The $25.74 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $79.44 · 2023: $48.62 · 2024: $68.09 · 2025: $25.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $142.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $249.80 | 2021 | |
| Abbott Laboratories | $58.33 | 2022-2023 | Cardiomems |
| Abbvie INC. | $35.00 | 2024 | |
| Merck Sharp & Dohme LLC | $33.09 | 2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $31.00 | 2023 | Xarelto |
| Exact Sciences Corporation | $25.74 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $22.56 | 2022 | |
| Pfizer INC. | $16.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Marte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.